|
Market Closed -
Xetra
20:38:38 12/11/2026 +04
|
After hours 00:15:53 | |||
| 56.56 EUR | -0.35% |
|
56.55 | -0.02% |
| 10:49pm | Pfizer to stop selling Premarin hormone therapy in Canada | RE |
| 11-11 | Drugmakers tap China AI app boom to reach doctors as crackdown upends marketing | RE |
| Market Cap | 55.76B 61.66B 51.47B 46.59B 87.92B 5,797B 90.55B 618B 246B 3,099B 231B 226B 9,864B | P/E 2026 * |
26.1x | P/E 2027 * | 18.9x |
|---|---|---|---|---|---|
| Enterprise Value | 85.54B 94.59B 78.96B 71.47B 135B 8,892B 139B 948B 377B 4,754B 355B 347B 15,131B | EV / Sales 2026 * |
1.86x | EV / Sales 2027 * | 1.75x |
| Free-Float |
100% | Yield 2026 * |
0.24% | Yield 2027 * | 0.93% |
| Markets | Quality | ||
|---|---|---|---|
Xetra
| BAYN | Delayed | |
| BAYNd | Real-time | ||
| BYR | Delayed | ||
| BAYN | Real-time | ||
| BAYN | Real-time | ||
| BYR | Real-time | ||
| 1BAYN | End-of-day quote | ||
| BAYN | Delayed | ||
| BAYN | Delayed | ||
| BAYZF | Delayed | ||
| BAYN | End-of-day quote | ||
| BAYN | End-of-day quote | ||
| BAY | End-of-day quote | ||
| BAYN N | End-of-day quote | ||
| BAYER | Delayed | ||
| BAYN | Delayed | ||
| BAY | Delayed |
Last Transcript: Bayer AG
| 1 day | -0.35% | ||
| 1 week | +0.60% | ||
| Current month | +11.82% | ||
| 1 month | +29.04% | ||
| 3 months | +17.83% | ||
| 6 months | +47.14% | ||
| Current year | +52.82% |
| 1 week | 53.84 | 57.84 | |
| 1 month | 43.08 | 57.84 | |
| Current year | 32.96 | 57.84 | |
| 1 year | 26.64 | 57.84 | |
| 3 years | 18.38 | 57.84 | |
| 5 years | 18.38 | 67.99 | |
| 10 years | 18.38 | 123.9 |
| Manager | Title | Age | Since |
|---|---|---|---|
William Anderson
CEO | Chief Executive Officer | 60 | 01/06/2023 |
Judith Hartmann
DFI | Director of Finance/CFO | 57 | 01/06/2026 |
Christian Rommel
CTO | Chief Tech/Sci/R&D Officer | 59 | 01/02/2021 |
| Director | Title | Age | Since |
|---|---|---|---|
André van Broich
BRD | Director/Board Member | 56 | 01/04/2012 |
Heike Hausfeld
BRD | Director/Board Member | 61 | 01/04/2017 |
| Chairman | 69 | 28/04/2020 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 18/03/26 | Buy | Director | 1,900 | 0.0002% | ||
| 18/03/26 | Buy | Executive/Senior Manager | 13,000 | 0.0013% | ||
| 18/03/26 | Buy | Director | 1,500 | 0.0002% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -0.35% | +0.60% | +94.63% | +40.52% | 61.87B | ||
| +0.02% | +5.10% | +40.92% | +134.09% | 1,280B | ||
| +1.70% | +4.47% | +46.36% | +92.71% | 675B | ||
| +0.27% | +2.49% | +26.66% | +113.07% | 521B | ||
| +1.14% | +3.78% | +39.98% | +70.26% | 386B | ||
| +0.39% | +0.62% | +61.67% | +44.28% | 363B | ||
| +1.11% | +0.07% | +28.19% | +58.61% | 301B | ||
| +0.24% | -0.80% | +3.05% | +35.93% | 286B | ||
| +0.09% | +1.72% | +39.22% | +75.55% | 253B | ||
| -0.24% | +0.82% | +36.90% | +125.46% | 211B | ||
| Average | +0.42% | +0.00% | +41.76% | +79.05% | 434B | |
| Weighted average by Cap. | +0.50% | +0.27% | +38.79% | +95.05% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 45.97B 50.84B 42.43B 38.41B 72.48B 4,779B 74.65B 509B 202B 2,555B 191B 187B 8,132B | 47.2B 52.2B 43.57B 39.44B 74.42B 4,907B 76.65B 523B 208B 2,623B 196B 192B 8,350B |
| Net income | 2.12B 2.34B 1.95B 1.77B 3.33B 220B 3.43B 23.43B 9.31B 118B 8.78B 8.59B 374B | 2.87B 3.18B 2.65B 2.4B 4.53B 299B 4.67B 31.85B 12.66B 160B 11.93B 11.68B 509B |
| Net Debt | 29.78B 32.93B 27.48B 24.88B 46.94B 3,095B 48.35B 330B 131B 1,655B 124B 121B 5,267B | 26.66B 29.48B 24.61B 22.28B 42.04B 2,772B 43.3B 295B 117B 1,482B 111B 108B 4,717B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 12/11/26 | €56.56 | -0.35% | 2,571,570 |
| 11/11/26 | €56.76 | -0.56% | 1,798,543 |
| 10/11/26 | €57.08 | +0.81% | 2,629,130 |
| 09/11/26 | €56.62 | +1.87% | 2,613,975 |
| 06/11/26 | €55.58 | -1.14% | 4,309,484 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
- Stock Market
- Stocks
- BAYN Stock
Select your edition
All financial news and data tailored to specific country editions
















